Yohimbine attenuates baroreflex-mediated bradycardia in humans

Hypertension

Volumn 50, Issue 5, 2007, Pages 899-903

  Tank, Jens ^a   Heusser, Karsten ^a   Diedrich, André ^b   Brychta, Robert J ^b   Luft, Friedrich C ^a   Jordan, Jens ^a,c  

^a FRANZ VOLHARD CLINIC   (Germany)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adrenergic; Antagonists; Baroreflex; Receptors; Sympathetic nervous system; Yohimbine

Indexed keywords

NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PLACEBO; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR; NORADRENALIN;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HEART RATE; HUMAN; MALE; NERVE CONDUCTION; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC NERVE; ADRENERGIC SYSTEM; BLOOD; CHOLINERGIC SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; PATHOPHYSIOLOGY; REFERENCE VALUE; TIME;

ADULT; BAROREFLEX; BLOOD PRESSURE; BRADYCARDIA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HEART RATE; HUMANS; MALE; NOREPINEPHRINE; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, ADRENERGIC, ALPHA-2; REFERENCE VALUES; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; YOHIMBINE;

EID: 35848953830     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.095984     Document Type: Article

References (35)

1. Grossman E, Rea RF, Hoffman A, Goldstein DS. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol. 1991;260:R142-R147.
2. Szabo B, Hedler L, Starke K. Peripheral presynaptic and central effects of clonidine, yohimbine and rauwolscine on the sympathetic nervous system in rabbits. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:648-657.
3. Goldberg MR, Hollister AS, Robertson D. Influence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans. Hypertension. 1983;5:772-778.
4. Sleight P, West MJ, Korner PI, Oliver JR, Chalmers JP, Robinson JL. The action of clonidine on the baroreflex control of heart rate in conscious animals and man, and on single aortic baroreceptor discharge in the rabbit. Arch Int Pharmacodyn Ther. 1975;214:4-11.
5. Elghozi JL, Head GA, Wolf WA, Anderson CR, Korner PI. Importance of spinal noradrenergic pathways in cardiovascular reflexes and central actions of clonidine and alpha-methyldopa in the rabbit. Brain Res. 1989;499:39-52.
6. Garty M, Deka-Starosta A, Chang P, Kopin IJ, Goldstein DS. Effects of clonidine on renal sympathetic nerve activity and norepinephrine spillover. J Pharmacol Exp Ther. 1990;254:1068-1075.
7. Veith RC, Best JD, Halter JB. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. J Clin Endocrinol Metab. 1984;59:151-155.
8. Tank J, Diedrich A, Szczech E, Luft FC, Jordan J. Alpha-2 adrenergic transmission and human baroreflex regulation. Hypertension. 2004;43:1035-1041.
9. Tank J, Jordan J, Diedrich A, Obst M, Plehm R, Luft FC, Gross V. Clonidine improves spontaneous baroreflex sensitivity in conscious mice through parasympathetic activation. Hypertension. 2004;43:1042-1047.
10. Murburg MM, Villacres EC, Ko GN, Veith RC. Effects of yohimbine on human sympathetic nervous system function. J Clin Endocrinol Metab. 1991;73:861-865.
11. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol. 1994;34:418-423.
12. Grossman E, Rosenthal T, Peleg E, Holmes C, Goldstein DS. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol. 1993;22:22-26.
13. Hedner T, Edgar B, Edvinsson L, Hedner J, Persson B, Pettersson A. Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers. Eur J Clin Pharmacol. 1992;43:651-656.
14. Grossman E, Chang PC, Hoffman A, Tamrat M, Goldstein DS. Evidence for functional alpha 2-adrenoceptors on vascular sympathetic nerve endings in the human forearm. Circ Res. 1991;69:887-897.
15. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105:116-124.
16. Mosqueda-Garcia R, Fernandez-Violante R, Tank J, Snell M, Cunningham G, Furlan R. Yohimbine in neurally mediated syncope. Pathophysiological implications. J Clin Invest. 1998;102:1824-1830.
17. Tank J, Diedrich A, Schroeder C, Stoffels M, Franke G, Sharma AM, Luft FC, Jordan J. Limited effect of systemic beta-blockade on sympathetic outflow. Hypertension. 2001;38:1377-1381.
18. Berger RD, Saul JP, Cohen RJ. Transfer function analysis of autonomic regulation. I. Canine atrial rate response. Am J Physiol. 1989;256:H142-H152.
19. Brychta RJ, Shiavi R, Robertson D, Diedrich A. Spike detection in human muscle sympathetic nerve activity using the kurtosis of stationary wavelet transform coefficients. J Neurosci Methods. 2007;160:359-367.
20. Willemsen JJ, Ross HA, Jacobs MC, Lenders JW, Thien T, Swinkels LM, Benraad TJ. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem. 1995;41:1455-1460.
21. Jie K, van Brummelen P, Vermey P, Timmermans PB, van Zwieten PA. Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans. J Cardiovasc Pharmacol. 1987;9:407-413.
22. Dawson R Jr, Nagahama S, Oparil S. Yohimbine-induced alterations of monoamine metabolism in the spontaneously hypertensive rat. I. The peripheral nervous system. Brain Res Bull. 1987;19:101-108.
23. Aggarwal A, Esler MD, Socratous F, Kaye DM. Evidence for functional presynaptic alpha-2 adrenoceptors and their down-regulation in human heart failure. J Am Coll Cardiol. 2001;37:1246-1251.
24. Jordan J, Tank J, Shannon JR, Diedrich A, Lipp A, Schroder C, Arnold G, Sharma AM, Biaggioni I, Robertson D, Luft FC. Baroreflex buffering and susceptibility to vasoactive drugs. Circulation. 2002;105:1459-1464.
25. Tank J, Schroeder C, Diedrich A, Szczech E, Haertter S, Sharma AM, Luft FC, Jordan J. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition. Circulation. 2003;107:2949-2954.
26. Eisenhofer G, Saigusa T, Esler MD, Cox HS, Angus JA, Dorward PK. Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits. Am J Physiol. 1991;260:R824-R832.
27. Ikeda Y, Kawada T, Sugimachi M, Kawaguchi O, Shishido T, Sato T, Miyano H, Matsuura W, Alexander J Jr, Sunagawa K. Neural arc of baroreflex optimizes dynamic pressure regulation in achieving both stability and quickness. Am J Physiol. 1996;271:H882-H890.
28. Kawada T, Miyamoto T, Uemura K, Kashihara K, Kamiya A, Sugimachi M, Sunagawa K. Effects of neuronal norepinephrine uptake blockade on baroreflex neural and peripheral arc transfer characteristics. Am J Physiol Regul Integr Comp Physiol. 2004;286:R1110-R1120.
29. Unnerstall JR, Kopajtic TA, Kuhar MJ. Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res. 1984;319:69-101.
30. Robertson HA, Leslie RA. Noradrenergic alpha 2 binding sites in vagal dorsal motor nucleus and nucleus tractus solitarius: autoradiographic localization. Can J Physiol Pharmacol. 1985;63:1190-1194.
31. Matko I, Feher E, Vizi ES. Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. Cardiovasc Res. 1994;28:700-704.
32. Bealer SL. Preoptic recess noradrenergic receptors control modification of baroreflex sensitivity by hypertonicity. Am J Physiol. 1999;276:R44-R51.
33. Chan CK, Burke SL, Head GA. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine. J Hypertens. 2007;25:147-155.
34. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484.
35. Lewis T. Vasovagal syncope and the carotid sinus mechanism. BMJ. 1932;1:873-876.